Gossamer Bio (GOSS) FCF Margin: 2022-2025
Historic FCF Margin for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -272.06%.
- Gossamer Bio's FCF Margin rose 6585.00% to -272.06% in Q3 2025 from the same period last year, while for Sep 2025 it was -790.58%, marking a year-over-year decrease of 78916.00%. This contributed to the annual value of -3.82% for FY2024, which is 118181.00% down from last year.
- Latest data reveals that Gossamer Bio reported FCF Margin of -272.06% as of Q3 2025, which was up 33.66% from -410.08% recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's FCF Margin registered a high of 1,671.52% during Q1 2024, and its lowest value of -410.08% during Q2 2025.
- In the last 3 years, Gossamer Bio's FCF Margin had a median value of 242.65% in 2024 and averaged 482.44%.
- As far as peak fluctuations go, Gossamer Bio's FCF Margin spiked by 15,755bps in 2024, and later slumped by 207,349bps in 2025.
- Over the past 4 years, Gossamer Bio's FCF Margin (Quarterly) stood at 1,383.63% in 2022, then plummeted by 35,170bps to 1,031.92% in 2023, then plummeted by 78,927bps to 242.65% in 2024, then surged by 6,585bps to -272.06% in 2025.
- Its FCF Margin stands at -272.06% for Q3 2025, versus -410.08% for Q2 2025 and -401.96% for Q1 2025.